IHS Chemical Week

People & Business :: M&A

GSK to spend $1 billion on raising stake in Indian subsidiary

3:40 AM MST | December 16, 2013 | Natasha Alperowicz

GlaxoSmithKline (GSK) today announced an offer to increase its stake in its publicly listed pharmaceutical subsidiary in India, GlaxoSmithKline Pharmaceuticals Ltd., from 50.7% to 75% at a price of 3,100 Indian rupee/share ($50.21). GSK intends to keep the company listed. Securities regulations in India require a minimum public shareholding of 25% for a company to maintain a public listing.   The offer is for the acquisition of up to 20,609,775 shares, representing 24.3% of the total outstanding shares of the Indian company. The offer represents a premium of...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa